\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ revealed\\ no\\ palpable\\ thyroid\\ nodule\\.\ \(0\)\
\-\ calcitonin\\ levels\\ \\>500\\ \\(elevated\\)\ \(0\)\
\-\ unknown\ \(157\)\
\-\ mri\\ demonstrates\\ a\\ nodule\\ in\\ the\\ left\\ thyroid\\ lobe\\ with\\ peripheral\\ t2\\ signal\\ peripherally\\ and\\ intermediate\\ signal\\ internally\\.\ \(0\)\
\-\ fusion\\ pet\\/ct\\ images\\ demonstrate\\ that\\ the\\ thyroid\\ nodule\\ is\\ fdg\\-avid\\.\ \(0\)\
\-\ ultrasound\\ images\\ demonstrate\\ that\\ the\\ nodule\\ is\\ hypoechoic\\ with\\ a\\ thin\\,\\ linear\\ echogenic\\ focus\\ and\\ a\\ small\\ cystic\\ area\\.\\ \\ there\\ is\\ mild\\ hyperemia\\ internally\\ and\\ peripherally\ \(0\)\
\-\ medullary\\ thyroid\\ carcinoma\ \(2\)\
\-\ medullary\\ thyroid\\ cancer\ \(2\)\
\-\ anaplastic\\ thyroid\\ cancer\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 45\\ year\\ old\\ male\\ with\\ an\\ incidentally\\ noted\\ left\\ thyroid\\ lesion\\ on\\ mri\\ and\\ pet\\/ct\\ examinations\\ during\\ work\\-up\\ for\\ an\\ unrelated\\ disorder\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.5607575840121541\ \(0\)\
\-\ nodule\\:\\ 0\\.3218276453308449\ \(0\)\
\-\ internally\\:\\ 0\\.2619946476383393\ \(0\)\
\-\ peripherally\\:\\ 0\\.21638108930421665\ \(0\)\
\-\ medullary\\:\\ 0\\.18030303848100843\ \(0\)\
\-\ calcitonin\\:\\ 0\\.1361380705768717\ \(0\)\
\-\ cancer\\:\\ 0\\.13579099195174452\ \(0\)\
\-\ hyperemia\\:\\ 0\\.11937162224959429\ \(0\)\
\-\ unrelated\\:\\ 0\\.11650637259579985\ \(0\)\
\-\ 500\\:\\ 0\\.11585649946584309\ \(0\)\
\-\ signal\\:\\ 0\\.1155673891770602\ \(0\)\
\-\ examinations\\:\\ 0\\.11136562583809782\ \(0\)\
\-\ demonstrate\\:\\ 0\\.10598570426468679\ \(0\)\
\-\ mri\\:\\ 0\\.10464811884488563\ \(0\)\
\-\ intermediate\\:\\ 0\\.10412015022641291\ \(0\)\
\-\ images\\:\\ 0\\.09430286245230872\ \(0\)\
\-\ echogenic\\:\\ 0\\.0934701995008316\ \(0\)\
\-\ that\\:\\ 0\\.0884713852480998\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.08709658175684123\ \(0\)\
\-\ incidentally\\:\\ 0\\.08684310883194667\ \(0\)\
\-\ focus\\:\\ 0\\.08634670075584813\ \(0\)\
\-\ disorder\\:\\ 0\\.08622472388914669\ \(0\)\
\-\ and\\:\\ 0\\.08425395593354233\ \(0\)\
\-\ is\\:\\ 0\\.08374625691964144\ \(0\)\
\-\ linear\\:\\ 0\\.08211610102038217\ \(0\)\
\-\ 45\\:\\ 0\\.08173385026140143\ \(0\)\
\-\ levels\\:\\ 0\\.08081253583742659\ \(0\)\
\-\ thin\\:\\ 0\\.07934770548763903\ \(0\)\
\-\ an\\:\\ 0\\.07795871962542979\ \(0\)\
\-\ peripheral\\:\\ 0\\.07289154929857845\ \(0\)\
\-\ palpable\\:\\ 0\\.07161262276724033\ \(0\)\
\-\ left\\:\\ 0\\.06954407161367239\ \(0\)\
\-\ elevated\\:\\ 0\\.06949001543093801\ \(0\)\
\-\ revealed\\:\\ 0\\.06683781797703593\ \(0\)\
\-\ area\\:\\ 0\\.06603455728220803\ \(0\)\
\-\ during\\:\\ 0\\.06456500016567218\ \(0\)\
\-\ cystic\\:\\ 0\\.06139160153150237\ \(0\)\
\-\ the\\:\\ 0\\.06101879938374421\ \(0\)\
\-\ carcinoma\\:\\ 0\\.060972531099336785\ \(0\)\
\-\ with\\:\\ 0\\.05988007033859335\ \(0\)\
\-\ lobe\\:\\ 0\\.058907292961067406\ \(0\)\
\-\ t2\\:\\ 0\\.05864565517456058\ \(0\)\
\-\ mild\\:\\ 0\\.0577836945885301\ \(0\)\
\-\ physical\\:\\ 0\\.05527115384138705\ \(0\)\
\-\ noted\\:\\ 0\\.05404545217980378\ \(0\)\
\-\ small\\:\\ 0\\.05258117956473707\ \(0\)\
\-\ exam\\:\\ 0\\.05131381138320278\ \(0\)\
\-\ demonstrates\\:\\ 0\\.05121071758809453\ \(0\)\
\-\ lesion\\:\\ 0\\.04886960318235529\ \(0\)\
\-\ male\\:\\ 0\\.045385101473347844\ \(0\)\
\-\ disease\\:\\ 0\\.04278842606235371\ \(0\)\
\-\ there\\:\\ 0\\.040559368318883196\ \(0\)\
\-\ no\\:\\ 0\\.03314789629765835\ \(0\)\
\-\ year\\:\\ 0\\.03141416502409168\ \(0\)\
\-\ for\\:\\ 0\\.030895524354449286\ \(0\)\
\-\ on\\:\\ 0\\.030785928539661177\ \(0\)\
\-\ old\\:\\ 0\\.03016847270621357\ \(0\)\
\-\ in\\:\\ 0\\.02535796234491114\ \(0\)\
